Celluma Light Therapy Welcomes New VP of Regulatory Affairs and Quality Assurance
Biophotas Inc., manufacturers of the award-winning Celluma SERIES of light therapy devices, recently welcomed Don Sherratt as its new Vice President of Regulatory Affairs and Quality Assurance. Don hails from Edinburgh Scotland and started his career in Research & Development in the medical device sector.
After receiving his BSc in Electronics Engineering in the United Kingdom, he began his career developing new and innovative technologies in several disciplines. Don transitioned to Regulatory Affairs and Quality Assurance and has more than 20 years of experience in senior management at both large and small companies. Don believes that quality begins in design and flows through manufacturing.
Before joining the executive team at BioPhotas, Don was VP of Quality for Endologix and prior to that he was Head of Operational Compliance for Philips N.V. Patient Monitoring, Ventilators and Defibrillation.
In providing unique devices founded on NASA-developed technology and backed by clinical studies, BioPhotas, manufacturer of the Celluma SERIES of light therapy devices, is bringing to market safe, effective and affordable devices that unlock the clinical power of biophotonics. BioPhotas develops and markets devices for healthcare providers and consumers that conveniently treat a variety of skin, muscle and joint conditions. For more information about the Celluma, please visit Celluma.com.